This message was sent to ##Email##
|
|
|
|
|
SCAI
Strategies to Incorporate BVS into Your Clinical Practice
Now that bioresorbable vascular scaffolds (BVS) are FDA approved, how do new adopters incorporate this technology into practice and where does BVS fit in with the treatment of more complex lesions?
David Rizik, MD, FSCAI, Cindy Grines, MD, FSCAI, Dean Kereiakes, MD, FSCAI, and Ashok Seth, MD, FSCAI, tackle this question in a SCAI-sponsored satellite symposium taking place Friday, May 12 at 12:15 p.m. CT.
SPACE IS LIMITED! Reserve Your Seat Today
Sponsored by SCAI. Supported through an educational grant from Abbott.
SCAI
With data from the SURTAVI Trial presented at ACC.17 closing the door on the argument over TAVR in intermediate risk patients and opening debate over low-risk patients, a critical new question arises for the interventional cardiologists: "How do we treat coronary artery disease (CAD) in TAVR patients?" James Hermiller, MD, FSCAI, will chair a symposium exploring answers to this very question on Thursday, May 11, at 12:15 p.m.
Jean-Michel Paradis, MD, FSCAI, Mauricio Cohen, MD, FSCAI, and Duane Pinto, MD, FSCAI, will join in the presentation discussing how and when percutaneous coronary intervention (PCI) should be performed in the TAVR patient, including tips, tricks, outcomes and case reviews. The panel will also look at coronary closure during TAVR and how to identify at risk patients.
With multiple studies and registry data demonstrating the prevalence of CAD in TAVR patients, ranging from 50 percent to 75 percent, this is a symposium you need to attend to optimize your patient outcomes.
Register Now
Sponsored by SCAI. Supported through an educational grant from Medtronic.
SCAI
Ted Feldman, MD, MSCAI, will chair this symposium delving into the latest outcomes data and practice strategies for Mitraclip and mitral valve therapies. Joining him in a dynamic discussion on the latest in mitral valve therapies and what the future may bring is a faculty of experts including Brian Whisenant, MD, FSCAI, and Mayra Guerrero, MD, FSCAI.
With more than 40,000 MitraClip cases having been conducted worldwide, this is an opportune time to examine what the community has learned, including which patients to refer for this therapy, key issues around registry reporting, and the critical role of imaging utilization before and after the procedure.
Register Now
Sponsored by SCAI. Supported through and educational grant from Abbott.
SCAI
Interested in optimizing patient outcomes — and the financial viability — of your CHIP program? Join Sunil Rao, MD, FSCAI, Adhir Shroff, MD, FSCAI, and Amit Amin, MD, for a lunchtime symposium, on Thursday, May 11.
With high-risk PCI on the rise, managing bleeding complications associated with the patient substrate becomes paramount. This symposium will explore how one of the key strategies to reduce PCI complications – transradial access – has often been misperceived as being applicable only in applicable mostly in patients and lesion subsets with mild to moderate complexity.
Additionally, the presenters will discuss the economic impact of adopting radial access for angiography and how PCI can optimize patient outcomes — and the economic realities — of CHIP centers throughout the U.S.
Register Today
Sponsored by SCAI. Supported through and educational grant from Medtronic.
SCAI
The Centers for Medicare & Medicaid Services (CMS) released a new informational booklet titled "NPI (National Provider Identifier): What You Need to Know." The booklet covers the National Plan and Provider Enumeration System, who must obtain an NPI, how to apply for an NPI, health care provider categories and more.
SCAI
The Medical Group Management Association (MGMA) has released their first "MIPS Tips" for optimizing financial performance in the MACRA Quality Payment Program. The American Hospital Association has also released the MACRA Primer for Hospital Board of Trustees, infographic, and the MACRA 101 Video Series.
SCAI
CMS announced on April 1 that physicians could begin registering in the Open Payments System and reviewing their CY2016 data. Disputes that are initiated before May 15 will be flagged in the public release on June 30. Physicians who do not review their data by May 15 are still encouraged to review their data before the end of the calendar year. Three ways to get answers to your questions: (1) read this article; (2) email Medicare's Open Payment Help Desk at openpayments@cms.hhs.gov; or (3) call (855) 326-8366.
TCTMD
Length of stay after elective PCI varies substantially among operators and hospitals, according to the results of a survey recently sent to interventional cardiologists in the United States, Canada, and the United Kingdom. Same-day discharge is routine in the U.K. but less so elsewhere, and most of the survey's 505 respondents said they were unaware of any guidelines for judging which patients need longer observation and who can safely be sent home the same day.
The main advice on the topic — an expert consensus document from the Society for Cardiovascular Angiography and Interventions — was released back in 2009.
READ MORE
Newcastle University via Medical Xpress
As we face a shortage of donated hearts for transplant, the study authors are calling for the devices to be considered as a tool which can allow patients to restore their health.
The research examined the effect of mechanical heart pumps, known as left ventricular assist devices.
READ MORE
 |
|
Chiesi USA, Inc., headquartered in Cary, NC, is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. Visit www.chiesiusa.com for more information.
|
|
Elsevier via ScienceDaily
Cardiothoracic surgeons are fully invested in the patient-centered, team-based model of care, guiding patients through the entire transcatheter aortic valve replacement (TAVR) experience, from the decision to undergo TAVR to discharge from the hospital and return to normal activities, according to a new survey published online in The Annals of Thoracic Surgery.
READ MORE
Cardiovascular Business
New findings on how cardiac muscle cells are damaged during surgery could point to emerging methods that will allow hearts to recover more quickly.
The research, completed by investigators at Cedars-Sinai Heart Institute in Los Angeles, was published in JCI Insight, the journal of the American Society for Clinical Investigation.
READ MORE
TCTMD
A tool incorporating clinical variables easily attainable in the cath lab accurately predicts risk of 30-day mortality in patients with cardiogenic shock occurring during acute MI, a study shows.
Using six factors derived from the IABP-SHOCK II trial — age, post-PCI TIMI flow, history of stroke and admission values of creatinine, glucose and arterial blood lactate — researchers led by Janine Pöss, MD, stratified patients into low-, intermediate- and high-risk groups; observed mortality rates were 23.8 percent, 49.2 percent and 76.6 percent, respectively.
READ MORE
| Date |
Event |
Location |
| May 10-13, 2017 |
SCAI 2017 Scientific Sessions |
New Orleans, LA
|
| June 13-16, 2017 |
Complex Coronary Valvular and Vascular Cases (CCVVC) 2017 |
New York, NY
|
| June 14-17, 2017 |
SVM 28th Annual Scientific Sessions
|
New Orleans, LA
|
| July 20-22, 2017 |
Complex Interventional Cardiovascular Therapy A Case Based Workshop- 11th Annual Meeting
|
San Francisco, CA
|
| August 3-5, 2017 |
Cardiovascular Innovations 2017 |
Denver, CO
|
| Dec. 9-12, 2017 |
SCAI 2017 Fall Fellows Courses |
Las Vegas, NV
|
For a complete list of job postings, click here.
To post your resume, click here.
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
